In addition, the histopathological examination showed that after the combinatorial therapy, magnetic-induced heating of the CD44-shRNA/DDP nanoliposomes in this study selectively targeted ovarian cancer tissues and caused no damage to the visceras including the heart, liver, spleen, lung, kidney, brain, and pancreas (Figure 8). The gene discussed is CD44; the disease is ovarian carcinoma.